Ysotope

Cancer remains one of medicine's greatest challenges. Advanced treatments like immunotherapy require precise identification of which patients will benefit. However, current methods based on partial biopsies are incomplete and unreliable, leading to high costs and limited efficacy.

This is where Ysotope comes in, a project that improves diagnostic precision in oncology patients using radiotracers that detect target molecules in over 95% of the tumor. This increases treatment efficacy and ensures the right patients are selected through non-invasive analysis.

The Ysotope team needed to present this potential to investors in a clear, rigorous, and visually striking way through their investor deck, landing page, and video. Our task was to simplify the project explanation as much as possible using engaging visuals, ensuring anyone outside the sector could understand the potential of their technology.